Cutler Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-400
| Closed | -$3.12K | – | 3033 |
|
|
2023
Q4 | $1K | Hold |
400
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q3 | $1K | Sell |
400
-400
| -50% | -$1.51K | ﹤0.01% | 3560 |
|
|
2023
Q2 | $2K | Hold |
800
| – | – | ﹤0.01% | 3049 |
|
|
2023
Q1 | $3K | Sell |
800
-200
| -20% | -$1.04K | ﹤0.01% | 2983 |
|
|
2022
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 3321 |
|
|
2022
Q3 | $3K | Sell |
1,000
-200
| -17% | -$501 | ﹤0.01% | 3980 |
|
|
2022
Q2 | $2K | Hold |
1,200
| – | – | ﹤0.01% | 4307 |
|
|
2022
Q1 | $4K | Hold |
1,200
| – | – | ﹤0.01% | 4293 |
|
|
2021
Q4 | $12K | Buy |
+1,200
| New | +$13.3K | ﹤0.01% | 3548 |
|
|
2019
Q1 | – | Sell |
-8
| Closed | – | – | 4442 |
|
|
2018
Q4 | $0 | Sell |
8
-9
| -53% | -$888 | ﹤0.01% | 4315 |
|
|
2018
Q3 | $2K | Buy |
17
+9
| +113% | +$1.09K | ﹤0.01% | 3524 |
|
|
2018
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 3867 |
|
|
2018
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 4890 |
|
|
2017
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 5464 |
|
|
2017
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 6324 |
|
|
2017
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 6747 |
|
|
2017
Q1 | $0 | Sell |
8
-390
| -98% | -$19.4K | ﹤0.01% | 6842 |
|
|
2016
Q4 | $15K | Buy |
398
+15
| +4% | +$608 | ﹤0.01% | 3756 |
|
|
2016
Q3 | $15K | Buy |
383
+266
| +227% | +$12.1K | ﹤0.01% | 3723 |
|
|
2016
Q2 | $8K | Sell |
117
-217
| -65% | -$17.2K | ﹤0.01% | 4430 |
|
|
2016
Q1 | $26K | Sell |
334
-118
| -26% | -$9.31K | ﹤0.01% | 3005 |
|
|
2015
Q4 | $34K | Buy |
+452
| New | +$72.6K | ﹤0.01% | 2865 |
|
Other funds holding LRMR
DM
RCM
BOCH
